Wednesday 8 June 2022 12:16 AM New vaccine developed by BioNTech and Genentech could prevent deadliest cancer ... trends now
Wednesday 8 June 2022 12:16 AM New vaccine developed by BioNTech and Genentech could prevent deadliest cancer ... trends now
New vaccine could prevent deadliest cancer returning as early tests suggest it could help stop pancreatic disease from coming back Cutting age vaccine for pancreatic cancer has been hailed by experts after trial Results suggest personalised vaccines could stop deadly disease returning Quarter of pancreatic cancer patients survive over a year as T cells not active 8 participants had cells recognise disease and remain cancer-free 18 months on
18 shares
View
comments
Experts have hailed a cutting-edge vaccine that could prevent pancreatic cancer from returning.
Early trial results suggest the personalised vaccines prime the body to stop the deadly disease coming back.
Only a quarter of patients survive for a year or more after diagnosis and pancreatic cancer often goes undetected because the immune system does not recognise the tumour cells as threats.
But a small subset of patients beat the odds after their tumour is removed. A team led by Dr Vinod
